FAM83B, A NOVEL MOLECULAR TARGET FOR LUNG SQUAMOUS CELL CARCINOMA.

被引：0
|
作者：
Okabe, Naoyuki [1 ]
Suzuki, Hiroyuki [1 ]
Higuchi, Mitsunori [1 ]
Osugi, Jun [1 ]
Hasegawa, Takeo [1 ]
Yaginuma, Hiroshi [1 ]
Muto, Satoshi [1 ]
Yamaura, Takumi [1 ]
Watanabe, Yuzuru [1 ]
Owada, Yuki [1 ]
Watanabe, Shinya [2 ]
Waguri, Satoshi [2 ]
Ezaki, Jyunji [2 ]
机构：
[1] Fukushima Med Univ, Dept Thorac Surg, Fukushima, Japan
[2] Fukushima Med Univ, Translat Res Ctr, Fukushima, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
FAM83B; SCC; lung squamous cell carcinoma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S484 / S485
页数：2
相关论文
共 50 条
  • [31] Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma
    Liu, Zeyu
    Wan, Yuxiang
    Qiu, Yuqin
    Qi, Xuewei
    Yang, Ming
    Huang, Jinchang
    Zhang, Qiaoli
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (10): : 1393 - 1405
  • [32] Novel methylation-driven genes identified as prognostic indicators for lung squamous cell carcinoma
    Li, Yin
    Gu, Jie
    Xu, Fengkai
    Zhu, Qiaoliang
    Ge, Di
    Lu, Chunlai
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (04): : 1997 - +
  • [33] Clinical significance of miRNA-1 and its potential target gene network in lung squamous cell carcinoma
    Li, Xiaojiao
    Qin, Meijiao
    Huang, Jiacheng
    Ma, Jie
    Hu, Xiaohua
    MOLECULAR MEDICINE REPORTS, 2019, 19 (06) : 5063 - 5078
  • [34] Identification of SLC38A7 as a Prognostic Marker and Potential Therapeutic Target of Lung Squamous Cell Carcinoma
    Haratake, Naoki
    Hu, Qingjiang
    Okamoto, Tatsuro
    Jogo, Tomoko
    Toyokawa, Gouji
    Kinoshita, Fumihiko
    Takenaka, Tomoyoshi
    Tagawa, Tetsuzo
    Iseda, Norifumi
    Itoh, Shinji
    Yamada, Yuichi
    Oda, Yoshinao
    Shimokawa, Mototsugu
    Kikutake, Chie
    Suyama, Mikita
    Unoki, Motoko
    Sasaki, Hiroyuki
    Mori, Masaki
    ANNALS OF SURGERY, 2021, 274 (03) : 500 - 507
  • [35] Establishment of Organoid Cell Lines from Lung Squamous Cell Carcinoma
    Shi, Ruoshi
    Radulovich, Nikolina
    Ng, Christine
    Akshinthala, Dipikaa
    Cabanero, Michael
    Li, Ming
    Pham, Nhu-An
    Tsao, Ming
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S978 - S978
  • [36] Cross-disease analysis identified novel common genes for both lung adenocarcinoma and lung squamous cell carcinoma
    Zhang, Guanghui
    Wang, Weijie
    Huang, Weiyang
    Xie, Xiaoli
    Liang, Zhigang
    Cao, Hongbao
    ONCOLOGY LETTERS, 2019, 18 (04) : 3463 - 3470
  • [37] Single-cell RNA sequencing analysis revealed cellular and molecular immune profiles in lung squamous cell carcinoma
    Hao, Bo
    Zhang, Ziyao
    Lu, Zilong
    Xiong, Juan
    Fan, Tao
    Song, Congkuan
    He, Ruyuan
    Zhang, Lin
    Pan, Shize
    Li, Donghang
    Meng, Heng
    Lin, Weichen
    Luo, Bin
    Yang, Jinfeng
    Li, Ning
    Geng, Qing
    TRANSLATIONAL ONCOLOGY, 2023, 27
  • [38] Molecular characterization of STEAP3 in lung squamous cell carcinoma: Regulating EGFR to affect cell proliferation and ferroptosis
    Shi, Hanqiang
    Lei, Siyu
    Xiong, Lie
    Du, Shuqin
    Shi, Yanbo
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 751
  • [39] Differential expression of sonic hedgehog in lung adenocarcinoma and lung squamous cell carcinoma
    Xu, L.
    Xiong, H.
    Shi, W.
    Zhou, F.
    Zhang, M.
    Hu, G.
    Mei, J.
    Luo, S.
    Chen, L.
    NEOPLASMA, 2019, 66 (05) : 839 - 846
  • [40] Molecular mechanisms of squamous differentiation in urothelial cell carcinoma: A paradigm for molecular subtyping of urothelial cell carcinoma of the bladder
    Adam, Rosalyn M.
    DeGraff, David J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (10) : 444 - 450
12345